(Q41646149)

6 October 2017

1 reference

title

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity (English)

1 reference

6 October 2017

1 reference

Ressing ME

1

1 reference

6 October 2017

Offringa R

2

1 reference

6 October 2017

Toes RE

3

1 reference

6 October 2017

Ossendorp F

4

1 reference

6 October 2017

de Jong JH

5

1 reference

6 October 2017

Brandt RM

6

1 reference

6 October 2017

Kast WM

7

1 reference

6 October 2017

Melief CJ

8

1 reference

6 October 2017

1 November 1996

1 reference

Immunotechnology : an international journal of immunological engineering

6 October 2017

1 reference

6 October 2017

2

1 reference

6 October 2017

4

1 reference

6 October 2017

241-251

1 reference

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Structure, function, and diversity of class I major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Peptide-induced conformational change of the class I heavy chain

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

T Cell Subsets and the Recognition of MHC Class

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Cellular studies on antigen presentation by class II MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Sequence analysis of peptides bound to MHC class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Immunity to Oncogenic Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Cellular immunity against DNA tumour viruses: possibilities for peptide-based vaccines and immune escape.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Viruses in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Viral immunopathology of human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Human papillomaviruses in the pathogenesis of anogenital cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Cellular immunity against human papillomavirus associated cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Identification of two cytotoxic T lymphocyte-recognized epitopes in the Ras protein

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

HLA antigens and cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Loss of MHC class-I expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Latent papillomavirus and recurring genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Role of cell-mediated immunity in spontaneous regression of plane warts

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

T cell priming versus T cell tolerance induced by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Antigen presentation to cytotoxic T lymphocytes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

New strategies for enhancing the immunogenicity of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1380-2933%2896%2900057-7

7 January 2021

10.1016/S1380-2933(96)00057-7

Identifiers

DOI

1 reference

6 October 2017

1 reference